Altair
Skip to content

Trading Analysis Report: TEAM

Analysis date: 2026-10-14 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Underweight
  • Generated: 2026-10-15 00:13:30
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Underweight TEAM at 204.66: trim toward target, do not exit, add or short. Before trading, confirm the earnings date and read the FY26 10-K, covering full-year FCF margin vs FY25, June-quarter FCF vs the vendor-implied ~$0.8B, and the SBC line. Target the lesser of half a standard allocation or 2% of portfolio; take 2.5% only if your book is not tied to the 10-year and FY26 FCF margin is within about 2 points of FY25. Drop the earlier 3% figure. If you are above target, sell half the excess now and rest the other half as a limit at 210-212, force-filled at the earlier of the last close before the print or the 10/28 close (excess only). On the remainder, halve on a daily close below the trailing daily SuperTrend (now 186.09, ratchets up only), halve again below 175.96, and exit on a weekly close below 154.21; flat holders should not buy. Horizon is 2-3 months, through the 10/29 FOMC, the next print, the 11/3 midterms and the 12/10 FOMC.

Price target: $199.50 (valuation objective). Method: scale the latest close by the DCF base-case value relative to market cap, 204.66 x (50.5 / 51.8) = 204.66 x 0.9749 = about 199.5. Cross-checks: the 10 EMA (200.38) and the Bollinger middle band (193.66) frame the same zone, and it matches the research plan's 193-200 rebuild area. Forward EPS of $6.74 at about 29.6x gives the same figure. The implied drift is modest (-2.5%), consistent with fair-to-slightly-rich valuation rather than a breakdown. The illustrative DCF is sensitive to the exit multiple (-27% to +22%) and to unverified margin inputs, so confidence is medium.

Current Price: 204.66

Price Target: 199.5

Confidence: Medium

Time Horizon: 2-3 months

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: I'll open, since neither of you has spoken yet, and I'll take your likely objections head on.

The call is to trim TEAM toward about half a standard allocation, capped near 3% of the portfolio, and I think it's the aggressive call, even though the word is "sell." Aggression doesn't mean riding a position at full size through a binary event cluster. It means taking an outsized gain, a stock up about 270% from its $56 low, while keeping a meaningful runner for the next leg. A trim does both.

Conservative analyst, I expect you'll say to exit entirely or short it. The tape doesn't support that. SuperTrend is up on the weekly, monthly and daily charts. The weekly TD count is -2 and the monthly is -5, so there's no higher-timeframe exhaustion. All three z-scores sit inside ±2, ADX is above 25, and revenue growth has gone 14% to 21% to 23% to 32% year over year. Shorting that is how people get run over. Even the one bearish voice in the sentiment data said he covered his shorts below $200. A full exit also gives up the upside if the breakout extends, and the weekly trend doesn't break until 154. So we keep the runner and say plainly that we don't short.

Neutral analyst, I expect you'll say the trend is intact, so hold. The trend being intact is why I'm not exiting, but it doesn't tell you what size to carry into what's coming. Look at the risk and reward from here. The 52-week high is 214.77, only 4.9% above the close, while the daily SuperTrend stop at 186.09 is 9.1% below. The nearest reward is about half the nearest risk. Even if you hand the bulls a run to 230, that's about 12% against 9%, and you'd have to sit through the 10/29 FOMC, the earnings print and the 11/3 midterms to collect it.

The momentum is also thinner than the price suggests. The daily TD-9 sell-setup is complete. 10/14 closed in the lower fifth of its range with a lower high. OBV is still below its 9/17 level while price made new highs, MACD is well under its 9/14 peak of 13.56, and the advance is on about 2.3M shares a day, against 20M+ on the gap days. A daily 9 alone is just a pause signal, and I'll concede that. But it comes with weak confirmation from volume and momentum, plus a rich valuation, plus an event cluster.

On valuation, the research plan's illustrative DCF comes to about $50.5B against a $51.8B market cap. That's only as good as its inputs, but it says the base case is already in the price. We pay about 30x forward non-GAAP earnings, about 7.9x sales and about 31x trailing free cash flow, and GAAP earnings are roughly zero. To make money from here you need a beat on top of a bull case that's already priced.

You'll both point to the trailing free cash flow of $1.655B, a 25% margin. That figure leans on a June quarter we can't see. Backing out the reported quarters leaves an implied $0.8B of free cash flow in that single quarter, and an implied revenue of about $1.77B, which is below March's $1.787B. Those are vendor arithmetic and unverified. What is verified is that nine-month free cash flow is down about 20% while revenue is up about 25%. The margin fell from 27.6% to 17.6%. Cash has halved to $1.24B, the current ratio is 0.78, and equity is a thin $1.06B. The insiders aren't buying either. The only open-market purchase in the table is one director's $248K at $148 back in December, and nobody bought near $56.

The rates backdrop adds to this. The 10-year hit 5.31% on 10/5, the highest since 2002, and Polymarket has a 24% chance of a hike on 10/29 with a 97% chance of no cuts this year. The VIX is at 15. I'll grant that TEAM has rallied through rising yields so far, so this is a tail risk and not a proven driver. But it is a tail risk against a stock that has gapped by 30-35% on big days in both directions this year, and that's why the stop doesn't protect us and position size does. At a 3% cap, a 30% gap costs about 1% of the portfolio. That's a price I'm happy to pay to stay in the game.

You may say we're missing the 10-K, the stock-based compensation line, June-quarter actuals, FY27 guidance and the earnings date, and that we can't act without them. I'd turn that around. Missing data is a reason to size down, not to wait. Waiting for a daily close below 186 means giving back about 9% first.

I won't pretend the trim is free. If TEAM clears 214.77 on expanding volume with OBV confirming, we'll have sold some of the move. I accept that. The runner still participates, and the rule is not to chase and not to add. If you're already at or below the target size, hold. If you're above it, trim into strength toward 210-215 before the FOMC, cut again by half on a daily close below 186.09, and exit fully on a weekly close below 154.21. Aggressive Analyst: Let me give up some ground first, because you've both earned it.

Conservative, you're right about the gaps. I said TEAM gapped 30 to 35 percent in both directions this year, and the price data shows two up-gaps, May 1 and August 7, and a three-month grind down. Neutral, you're right that I leaned on weak evidence. OBV sits about one average day of volume below its September level. The MACD peak was inflated by the August gap rolling out of the averages. And 2.3 million shares a day isn't thin for this stock, since it traded 1 to 3 million through late 2025. I'll also drop the 270 percent headline, the sentiment tags, the insider silence near $56 and the implied June quarter. Nine-month free cash flow down 20 percent looks less alarming once you see it's mostly one December quarter with a $1.14 billion investing outflow, narrowing to minus 12 percent in March. I'd add that operating margin is worse year over year in September, better in December and worse in March, so it's noise around minus 3 percent and not a clean trend.

What's left is still enough for a trim. The base case looks priced: the DCF is about $50.5B against a $51.8B market cap, at 30x forward earnings and 31x free cash flow. We can't see the June quarter, FY27 guidance or the earnings date. Rate risk has no clean all-clear, with 82 percent odds on another hike by December 10. None of that says the stock falls. It says a full position pays too little for being wrong, which is a sizing argument. That's why this is a trim and not a short.

Now to the conservative's quarter allocation. Your 1.5 percent cap comes from a half-percent loss budget, and as neutral said, that's a preference, not a finding. You also concede the tape isn't broken and the fundamentals are accelerating. A quarter of standard doesn't fit that. It's a position you've already mentally sold.

Run my full rule set through the ugliest grind. Start at 3 percent. The first half goes at 186, about 9 percent down on 1.5 points, so roughly 14 basis points. The second half goes at the weekly stop near 154, about 25 percent down on 1.5 points, so roughly 37 basis points. That's about half a percent of the portfolio before slippage, which is your own budget. At a 1.5 cap the same path costs 37 basis points, so what I'm asking you to carry is the 14-basis-point difference.

You also paired two complaints that cancel out. Stops are weak against gaps and slow against grinds. But a trend stop is built for grinds, and its give-back is the 14 basis points above. For gaps, sizing is the control, and I've said so. A 30 percent gap down on 3 points costs 90 basis points, but a 30 percent gap up earns 90 on the way back. Both big gaps we can see went up. They came off much lower prices and lower expectations, so I won't call the next one a gift. I'm only saying nothing in the data shows the downside gap you're sizing for.

Neutral, I'll take your deadline. A trim into strength with no date is a wish. So do half the excess now and the rest toward 210 to 212, near the upper Bollinger band, with the hard stop being the 10/28 close or the day before the print, whichever comes first. Confirm the earnings date first. The 82 percent December hike odds are also the best argument for acting now, because there's no all-clear date to wait for.

On size, your 2 to 2.5 percent versus my 3 is worth 15 to 30 basis points in a 30 percent move. I won't fight over that. If the book is heavy in long-duration growth, go to two. The plan already says half of standard, capped near 3, so the cap binds below 3 for most people. It's also already conditional: if you're at or below target, hold and don't add.

I'm also not trimming because the daily nine fired. A daily nine is a pause signal, and I said so. I'm trimming near the highs, about 5 percent from 214.77, while the weekly and monthly structure is intact, so I'm not selling into a broken tape.

Aggression here means sizing to survive a bad print so you still own the next leg. A cap near half does that, and a quarter doesn't. If TEAM clears 214.77 on expanding volume with OBV confirming, we don't chase and we don't sell the runner. I'm keeping the Sell as a trim. Aggressive Analyst: Three of the corrections are mine, so I'll start there.

Neutral, you're right on the grind math. I let the 1.5 percent holder sit untouched down to 154. A holder who follows the same halving rule at 186 pays about 25 basis points, not 37, so the extra size cost 25, not 14.

Conservative, you're right on free cash flow. I used the December investing outflow as if it explained the nine-month decline, and investing flows aren't in free cash flow. Capex that quarter was nine million dollars. I also called March a narrowing, which is true in dollars and false in margin. March was about 31 percent against 47 a year earlier, and December was 10.7 against 26.7, so that's roughly 16 points of compression in both quarters. It's a live question, and I won't use it to defend holding more. It's the reason for the cap. I'll also stop saying nothing in the data shows a downside gap. The January to April slide ran on five to fourteen million shares a day, and a summary table doesn't tell us what happened inside it. The honest line is that the data doesn't settle it, so we size for it.

I'll take the 175.96 rung. It's the 9/29 close, it sits at the lower Bollinger band, and it's under the 50-day, so a daily close there is a structural break and not noise. Run the grind with the full ladder: halve at 186, halve again at 175.96, out at 154. A 3 percent holder pays about 43 basis points, a 2.5 percent holder about 36, and a 2 percent holder about 28. The middle rung shrinks the price of the bigger size. The gap between 2.5 and 2 is about 7 basis points in the grind and about 15 in a 30 percent gap, in either direction. I'll meet neutral at 2.5 percent as the default and 2 percent for a book heavy in long-duration growth. The 3 percent in the plan is a ceiling that shouldn't bind for most people. I won't spend credibility on 7 basis points.

Now the places where I still disagree. Conservative, you said a 30 percent up-gap puts TEAM near 266, about 10 times sales, and that this isn't compensation for carrying size. But that's a statement about what I'd do after the gap, and I've already said I wouldn't chase or add. It's also exactly the scenario where a runner is worth owning. A 2 to 2.5 percent position costs 60 to 75 basis points if the print goes wrong and pays about the same if it goes right. That's the price of owning the next leg of a business growing 32 percent with an intact weekly and monthly trend.

Neutral, I'd soften your 1.9 percent figure. It assumes none of the exits work through a 64 percent decline. A three-month slide has a lot of closes in it, and the ladder only needs one close under 186 to start working. A holder is only fully exposed if nearly the whole slide gapped through 186, 176 and 154. Neither of us can rule that out, which is why size is the main control. But the realistic cost of a slide is closer to the 30 to 40 basis points of the ladder than to 1.9 percent.

On execution, neutral's arithmetic settles it for me. Carrying the second tranche through a normal pullback costs about 7 basis points, and missing a run to 215 costs about 5, so it's a wash. Half the excess goes now. The second half rests as a limit at 210 to 212 and gets a forced fill at the 10/28 close or the day before the print, whichever comes first, after we confirm the date. That deadline is what turns the plan from a wish into a rule, and conservative, it answers your concern about drifting.

On the path back, I side with neutral. The trim exists because of missing information: the June quarter, FY27 guidance and the earnings date. Once the print answers those, the reason is gone. Requiring a weekly close above 214.77 would mean rebuilding after a gap at 266 and calling that discipline. Rebuild to target if the trend holds and guidance isn't a miss. Go above target only on a new high with expanding volume and OBV confirming, or when the hike odds ease. Conservative, I agree "do not add" shouldn't expire on 10/30. It just shouldn't become "never rebuild."

My worry is that we each keep shaving a little more until the position is too small to notice when it works. This stock went from 57 to 205 on accelerating growth, and we aren't going to know in advance which print reprices it. The plan caps the cost of being wrong at roughly 30 to 45 basis points in a grind and 60 to 75 in a gap, and it keeps real participation if the breakout extends.

So I'm keeping the Sell as a trim. If you're at or under about 2.5 percent, or 2 in a growth-heavy book, hold and don't add. If you're above that, cut half the excess now and the rest by the deadline. Halve on a close below 186.09, halve again below 175.96, and exit on a weekly close below 154.21. Don't short, and don't buy if you're flat. Aggressive Analyst: Most of this is settled, so I'll take what I'm giving up and push where I still disagree.

Neutral, your point that most of what we call missing is missing from our tools, not from the world, is the best thing said this round, and it changes my argument. I told you earlier that missing data is a reason to size down. That holds for a trader who can't close the gap, but this caller can. The balance sheet runs through June 30, so the 10-K and the June quarter very likely exist. That's an inference, but it's cheap to check. The right order is to read first and size second, and it works in my favor. If June-quarter free cash flow is nowhere near the implied $0.8B and trailing margin is sliding, the holder sits at 2%. If it reconciles near the vendor's 25% and the book isn't tied to the 10-year, the holder gets 2.5% and the trim is smaller. I'll take your rule for choosing between them.

Conservative, that also settles the default. Someone who doesn't know their book gets 2%, and I'm fine with that. The gap to 2.5% is half a point of portfolio times a 30% move, about 15 basis points, and I won't spend more credibility on it.

I still disagree on two things. The first is your point that my ladder numbers are floors. You're right that close-based rungs fill the next session, and that a hawkish gap could take TEAM through 186 and 176 together. If that gap is 30%, it lands near 143. A 2.5% holder loses 75 basis points and a 2% holder loses 60. That's the gap cost we've been using all along, and the cap already prices it. Neutral is right that citing it again to push the default lower counts it twice. Slippage is real but small. A full ATR of slippage, about 4% of price, on the first rung of a 2.5% holder is roughly 5 basis points.

The second is symmetry. You say nothing shows the up-gap and down-gap are equally likely, and I agree. But nothing shows the downside is more likely either. What we have is a DCF near market cap, and that DCF is illustrative and only as good as its inputs. Neutral read it correctly as expected return roughly equal to required return. I'm not claiming an edge for the extra half point of size. I'm saying that at 2.5% it's cheap enough that I don't need one. A fair price for the risk is a reason to hold a position sized for what you can lose, not zero and not the 3% I started with. The up-gap case also isn't hypothetical. If the trim leaves a holder with nothing meaningful, a 30% print pays them almost nothing, and that's the outcome I'm trying to avoid.

On the rebuild rule, Neutral's seasonality point settles it. The September quarter is the thinnest for cash. Free cash flow was $74M in Sep-24 and $115M in Sep-25, about 6% and 8% of revenue. A test that asks the next print to show compression stopping would either block a rebuild for the wrong reason or pass on noise. The compression we care about was in December and March, and this print doesn't cover those quarters. So the test should be trailing four-quarter free cash flow margin staying near the vendor's 25% instead of drifting toward the 17.6% nine-month figure, with the June quarter reconciled to the 10-K. Conservative, I take your SuperTrend condition. If the ladder fired, the daily SuperTrend flipped, so waiting for it to turn back up just confirms the trend is intact again. We may rebuild at a higher price than we sold, and that's the cost of having a rule. "Do not add" shouldn't lapse on 10/30, but it also shouldn't become "never rebuild."

On the worry about shaving, all three of us have moved. I went from a 3% cap to 2.5%, Conservative went from a quarter of standard to 2%, and Neutral built the middle. A position that earns 60 to 75 basis points on a 30% gap up is not being shaved into irrelevance. It's sized so that a bad print costs a rounding error, which lets us hold the name through the 10/29 FOMC, the print and the midterms and still own the next leg if the breakout extends.

So I'm keeping the Sell as a trim. Check the earnings date and read the filings first. Target the lesser of half a standard allocation or 2.5%, or 2% if the book is growth-heavy, unknown, or the filings disappoint. If you're above target, cut half the excess now. Rest a limit at 210 to 212 for the rest, with a forced fill at the earlier of the 10/28 close or the day before the print. Halve on a daily close below 186.09, halve again below 175.96, and exit on a weekly close below 154.21. If you're at or below target, hold and don't add. If you're flat, don't buy, and don't short at any point. Aggressive Analyst: Let me take the corrections first, because you've both earned them.

Conservative, the ratchet is right. The trader's own text calls 186.09 the daily SuperTrend line, and that line only moves up. I can't argue for keeping a runner and also defend a stop sitting twenty percent under the price when the runner is working. With TEAM at 230 and a fixed 186, I'd be tolerating the give-back I criticized earlier. So the first rung trails the daily line on a closing basis and never moves down. Neutral's caveat is fair too. Once the line climbs past the top of the September range, a normal pullback in a working trend can halve the position, and 175.96 becomes a deep backstop. I'll take that whipsaw. It only happens when we're ahead, the position is already at target, and the rebuild rule exists for that case.

On the rebuild test I'm with Neutral. Conservative, your same-quarter check is the best new idea in the thread, because September against September removes seasonality. But 8% is a line drawn through a small number. September 2025 was 8.0%, $115M on $1,433M, and September 2024 was 6.2%, $74M on $1,188M. At roughly 30% growth, 8% is about $150M, and a few tens of millions of working-capital timing moves it either way. So a clear miss, a margin back near last year's 6%, blocks the rebuild, and 7.6% doesn't. Stack enough vetoes and "rebuild" quietly becomes "never." The trailing four-quarter test moves to the pre-trade check, where Neutral put it, because it's really a June-quarter question and the 10-K can answer it today.

I'd sharpen that check with your same-quarter logic. The 10-K gives fiscal-year free cash flow, so the caller can back out June 2026 as the fiscal year minus the $845M we have for nine months. They can do the same for June 2025 against $1,056M. If June 2026 lands near the vendor's implied $0.8B and its margin isn't worse than last June, the December and March compression looks lumpy, and the holder can take 2.5% if the book allows. If it doesn't reconcile, or it's worse than last June, they take 2%. That gives "filings disappoint" the kind of definition Conservative has been asking for.

On August, I concede, and I'll say what it costs me. If that gap was the fiscal Q4 report, the market had the June quarter and guidance when it paid up 35%, then added another 37% from 149 with no new print. So reading the filings isn't an edge. It's a sanity check on a vendor number that looks off, and it should only move someone between 2% and 2.5%. A clean 10-K doesn't earn more, and I agree the 3% should come out of the written plan entirely.

Neutral, you're right about my wording. Sixty to seventy-five basis points isn't a rounding error, and "it pays the same if it goes right" is arithmetic, not an edge. The honest case for holding anything is this. We have no proven expected-return edge. We have an intact weekly and monthly trend, ADX above 25, no stretched z-scores and revenue growth that went from 14% to 32%. Against that sits an illustrative DCF near market cap. With the center of the distribution roughly fair and fat tails on both sides, you can't justify a big position, and you can't justify zero either, because zero guarantees you miss the leg if the print is good. That's the whole case for 2.5% over 2%. It's cheap enough to carry if your book isn't tied to the ten-year.

I also agree the forced fill touches only the excess above target and never the target position. And if you're within about a quarter point of target, skip the trim.

Here's why I still call this the aggressive choice. The next three weeks hold a 10/29 FOMC with a 24% hike probability, an undated print and the midterms. Hike odds are 82% by December 10, the 10-year sits at 5.2% after touching 5.31%, and the VIX is at 15. TEAM is up about 18% in ten sessions. None of us can say which event reprices it. We can only choose how much of each to underwrite. At 2% to 2.5%, a 30% gap down costs 60 to 75 basis points, a 30% gap up earns the same, and a grind through the full ladder costs 28 to 36. That's survivable, and it keeps real participation. The aggressive move isn't the biggest position going into the cluster. It's still owning the name, with capital and conviction intact, when the next leg arrives.

So I'm keeping the Sell as a trim. Confirm the earnings date and read the 10-K first. Target the lesser of half a standard allocation or 2.5%, or 2% if the book is growth-heavy, unknown, or the June quarter disappoints. If you're above target, cut half the excess now. Rest a limit at 210 to 212 for the rest, with a forced fill at the earlier of the 10/28 close or the day before the print. On what remains, halve on a close below the trailing daily line, currently 186.09, then halve again below 175.96. Exit on a weekly close below the weekly line, currently 154.21. If you're at or below target, hold and don't add. If you're flat, don't buy, and never short. After the print, rebuild only to target, and only once the daily line is back up, June has reconciled and September's margin isn't clearly worse than last year's. Going above target needs a new high on expanding volume with OBV confirming, or hike odds fading, and December 10 is the next marker.